JNGLX
Janus Henderson Global Life Sciences Fund - D Shares
$93.52
Janus Henderson Global Life Sciences Fund - D Shares (JNGLX)
This fund aims to achieve its investment objective by typically allocating a minimum of 80% of its net assets (plus any capital borrowed for investment purposes) to companies that the portfolio manager believes exhibit a life science orientation. As a fundamental principle guiding its pursuit of life science-focused companies, the fund also has a policy to normally invest at least 25% of its total holdings in businesses formally classified within the "life sciences" sector.
JNGLX Mutual Fund Chart & Stats
$93.52
- Previous Close
- $93.52
- Sub-Category
- Sector-Specific
- Total Liabilities
- $11.19M
- Last Dividend Ex-Date
- Dec 05, 2025
- Expense Ratio
- 0.81%
- Holding Count
- 84
- Brand
- Janus Investment Fund
- Dividend Yield
- (3.95%)
- Category
- Equity
- Total Assets
- 5.82B
- Shares Outstanding
- N/A
- 52-Week Range
- $75.42 - $96.16
JNGLX Mutual Fund Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| LLYEli Lilly And Company | 9.41% |
| JNJJohnson & Johnson | 7.09% |
| ABBVAbbvie | 4.67% |
| UNHUnitedhealth Group Inc. | 4.54% |
| AZNAstraZeneca plc | 3.93% |
| RVMDRevolution Medicines, Inc. | 3.02% |
| ARGXArgenx | 2.63% |
| NVSNovartis AG | 2.56% |
| TMOThermo Fisher Scientific | 2.33% |
| PRAXPraxis Precision Medicines, Inc. | 2.19% |
| Total | 42.37% |
Recently Viewed
No data currently available






